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Abstract 
NM23 proteins NDPK-A&B bind to the cystic fibrosis (CF) protein CFTR in different ways 
from kinases such as PKA, CK2 and AMPK or linkers to cell calcium such as calmodulin and 
annexins. NDPK-A (not-B) interacts with CFTR through reciprocal AMPK binding/control, 
whereas NDPK-B (not -A) binds directly to CFTR. NDPK-B can activate G-proteins without 
ligand-receptor coupling, so perhaps NDPK-%¶VELQGLQJLQIOXHQFHVHQHUJ\VXSSO\ ORFDO WRD
nucleotide binding site (NBD1) needed for CFTR to function. Curiously, CFTR (ABC-C7) is a 
membHURI WKH$73%LQGLQJ&DVVHWWH$%&SURWHLQ IDPLO\ WKDWGRHVQRWREH\ µFODQUXOHV¶
CFTR channels anions and is not a pump, regulates disparate processes, is itself regulated 
by multiple means and is so pleiotropic that it acts as a hub that orchestrates calcium 
signalling through its consorts such as calmodulin/annexins.  Furthermore, its multiple 
partners make CFTR dance to different tunes in different cellular and subcellular locations as 
it recycles from plasma membrane to endosomes. CFTR function in airway apical 
PHPEUDQHV LV LQKLELWHG E\ VPRNLQJ ZKLFK KDV EHHQ GXEEHG µDFTXLUHG &)¶  &)75 DORQH
DPRQJVWIDPLO\PHPEHUVSRVVHVVHVDWUDSIRURWKHUSURWHLQVWKDWLWXQIXUOVDVDµILVK-QHW¶DQG
which bears consensus phosphorylation sites for many protein kinases, with PKA being the 
PRVWFDQRQLFDO5HFHQWO\WKHVLWHRI&)75¶VFRPPRQHVWPXWDWLRQKDVEHHQSURSRVHGDVD
knock-in mutant that alters allosteric control of kinase CK2 by log orders towards calmodulin 
and other substrates after CFTR fragmentation.  This link from CK2 to calmodulin that binds 
the R region invokes molecular paths that control lumen formation which is incomplete in the 
tracheas of some CF-affected babies.  Thus we are poised to understand the many roles of 
NDPK-A and B towards CFTR function and, especially lumen formation, which is defective in 
the gut and lungs of many CF babies. 
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Introduction 
Nucleoside diphosphate kinases (NDPKs/NME) are multi-functional proteins expressed as 
far apart as the amoeba Dictyostelium and modern humans.  Humans have ten NDPK 
genes, NME (non-metastatic) 1-9 and RP2, retinitis pigmentosa 2 whereas simpler 
organisms typically have about one to three isoforms.1, 2 NDPKs are classified into two 
groups (I and II) based on their sequence identities and capacity for high-energy 
phosphotransferase activity. Herein, we will refer to µ1'3. DFWLYLW\¶ DV that role which is 
dependent on 1'3.¶Vinternal phosphohistidine as a high energy source to effect change in 
another moiety. Thus group I genes encode proteins with NDPK activity and comprise NME1 
± 4 (also known as NDPK-A, -B, -C, and -D; or Nm23-H1 - H4). These share higher 
sequence identity (58 ± 88%) compared to group II, the latter additionally have low or no 
NDPK activity and share only about 22 ± 44% sequence identity.  Group I NDPKs (A - D) 
generate nucleoside triphosphates E\FRYDOHQWO\WUDQVIHUULQJWKHȖ-phosphate from a donor 
nucleoside (or deoxy) triphosphate (NTP or dNTP, respectively) to an acceptor nucleoside 
(or deoxy) diphosphate (NDP or dNDP) in a ping-pong reaction using the high-energy 
phosphohistidine intermediate3, 4. These NDPKs (perhaps as multimers) can also function as 
mammalian histidine protein kinases5 but, curiously, also SRVVHVVƍ-ƍ-exonuclease activity6 
which is important in DNA repair. This mini-review provides a summary of the current 
knowledge of the functions of two isoforms from group I in airway epithelia highlighting the 
role NDPKs might play in provision of energy for processes related to the protein whose 
mutation causes cystic fibrosis (CF).7 
In the airway, ciliary clearance of inhaled contaminants entering the respiratory system 
prevents lung infections and is dependent upon transport of chloride and other anions into 
the lumen of the airways, accompanied by water and mucus movement. In CF, a disease 
mostly caused by just one in-frame triplet nucleotide deletion in the CF gene (the cystic 
fibrosis transmembrane conductance regulator, CFTR), lack of normal fluid and mucus 
transport results in an abnormal airway surface liquid (ASL) layer that accumulates thick 
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mucus with frequent lung infections from a host of unusual microorganisms.8-11 Cell calcium 
plays a critical role in exocytotic mucus release and recently, CFTR has been shown to bind 
calmodulin, which might link anion transport to the viscid mucus found in CF airways.12 The 
CFTR anion channel also recycles using endosomes to and fro from the apical surface of 
many epithelial cells and is a key hub that generates a macromolecular complex including 
both sodium and potassium channels, anion exchangers, transporters that export cAMP, and 
other regulatory molecules.13 We will return to this theme of CFTR as an input and output 
hub later in the review when we consider the molecular events leading to embryonic 
tracheogenesis where calcium-dependent exocytosis is used (in fetal life) to build a tracheal 
lumen.14 
We have been interested in the constitutive protein phosphorylation of membrane proteins 
purified from airway epithelia and its relationship to ion transport and CFTR function for a 
number of years.15-18 Our work was initiated by our discovery that, provided sodium was 
absent in vitro, chloride concentration could act as a signal to purified apical membranes by 
regulating acid-labile phosphorylation of a number of soluble and membrane-bound 
proteins.19 In CF, it is established that mutation of CFTR causes a very low residence time 
and high degradation rate for the mutant (F508-deleted) protein which somehow enhances 
the function of epithelial sodium channels in a chloride-dependent manner.20 Later, we 
identified that chloride-sensitive proteins such as NDPK, annexin A1 are phosphorylated on 
histidine residues; for annexin A1 this occurs near the conserved calcium binding domain of 
this regulator of inflammation and steroid signalling.15, 17, 21-23 Inhibition of NDPK by non-
hydrolysable nucleoside analogues abrogated histidine phosphorylation of annexin A1.15 
Other members of the annexin family are also implicated in CF disease and these will be 
discussed below but we note that independent confirmation of the complex role of annexin 
AI in CF pathophysiology has been reported in the last few years.24 
CFTR is a member of the ATP-binding cassette (ABC) transporter/pump superfamily, which 
comprises membrane-anchored and µscissor shaped¶ transmembrane proteins that use the 
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energy from adenosine triphosphate (ATP) cleavage to translocate a range of molecules 
across many different cellular membranes. $%&¶VDUHone of the largest and oldest protein 
families, with members found in all phyla.  Over forty members are involved in essential 
processes in eukaryotic cells where their mutation causes disparate human diseases. 25-27 
They are multi-domain, and often self-assemble in lower orders in a multi-subunit manner 
comprising transmembrane domains (akin to scissor blades) bound to paired cytosolic 
clamps for ATP binding domains bearing at least one membrane-associated ATPase -
domain. Such domains trap two ATP molecules between their two cognate, inverted and 
opposed halves. CFTR channel function is driven by one ATP binding site acting as a non-
hydrolysing 'degenerate' ATP holding 'bridge-like' domain with the other site permitting free 
hydrolysis that enables other domain shifts to facilitate pore access. The relationship 
between ATP binding and channel gating is a very complex process as reviewed recently by 
Zwick et al.7  However, these models take no account of the binding of CFTR-associated 
proteins that drive a cAMP or calcium-dependent CFTR activation12, 18 or to the possibility 
that CFTR might also become a (protease) split molecule that could recombine its N and C 
terminal fragments28 in the membrane to create an array of different CFTR halves that add to 
the diversity of CFTR molecules in the membrane.  It is accepted that hydrolysis of clamped 
ATP drives conformational changes in the translocator µEODGHV¶ structure, fuelling the 
transport of biological substrates across the cellular membranes. 26, 27 Thus a typical 
structure of an ABC transporter comprises two transmembrane domains (TMDs), which are 
formed by sL[ WUDQVPHPEUDQHĮ-helices with the pump energy supplied from two opposed 
cytoplasmic nucleotide-binding domains (NBDs)26 bridged by two spatially separated ATP 
molecules.  However, CFTR is a most unusual member of the ABC transporter family in that 
it is the only member that forms a transmembrane ion channel in which the ATP-driven 
changes in the cytosolic domains of the protein conformation result in the opening and 
closing of a distant gate at the entrance to the anion pore, allowing for the flow of pre-
dehydrated anions (chloride, bicarbonate and other anions) down the prevailing 
electrochemical gradient 29, 30. In that sense, CFTR is a regulated slave to the direction of the 
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gradient of potential which means that anions can flow in or out of the cell RQDQµDVUHTXLUHG¶
basis, even against a concentration gradient. Hence&)75 LV WKHHTXLYDOHQWRIDQ µLI WKHQ
HOVH¶ VWDWHPHQW LQ WKH FHQWUDO SURFHVVLQJ XQLW RI D FRPSXWHU SURJUDPPH FRQWUROOLQJ D
complex circuit bearing many other components and it is these regulators that form the focus 
of our review. This complexity idea provides a backdrop to the many roles of CFTR which 
seems to create causal actions at a distance from the channel through its many partners. 
CFTR protein structure remains to be fully elucidated 
The CFTR protein comprises a regulatory domain (R domain or R region), two 
transmembrane domains, TMD1 and TMD2, and two homologous (but non-identical) 
inverted and opposed nucleotide-binding domains, NBD1 and NBD2.25, 31-33 
Electrophysiology suggests that the ion channel formed between the TMD domains of the 
CFTR protein opens when two different ATP molecules are bound WR &)75¶V two NBD 
domains. Conversely, closing of the channel gate follows a cycle of ATP hydrolysis, which 
leads to a different type of NBD1-NBD2 interaction and thus, to the termination of the flow of 
anions through the channel.29  This complex gating cycle KDV D VHFRQG µif then else 
FRQWUROOHU¶ LQ WKDW the protein kinase-mediated phosphorylation of an unstructured 
cytoplasmic R- domain of CFTR is required to permit the channel-gating cycle.  This unique 
(to ABC proteins) cytoplasmic R domain interacts with the two NBDs and is an integral part 
of CFTR protein that links NBD and TMD domains. The R region has multiple adjacent target 
sites for Protein Kinase A (PKA, a cAMP-activated protein kinase) phosphorylation which 
imparts a net double-digit negative charge to the protein.31, 34, 35  Thus, the central domain 
structure organisation of the single polypeptide 1480-amino-acid long wild type CFTR protein 
encompasses TMD2±NBD2±R±TMD1±NBD1.10, 35  How such a system operates in an intact 
cell is not agreed with some recent data even suggesting that NBDs may be permissive for 
CFTR phosphorylation7. We will return to the N-terminus and the C-terminus later when we 
(respectively) consider t-SNARES of the syntaxin family and protein kinases such as CK2 
and AMPK along with linkers from the DTRL motif at the end of CFTR to the cytoskeleton 
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such as ezrin. Interestingly, the origins of the capture and insertion of the R domain in CFTR 
are unknown as no significant sequence homology with other proteins has been found to 
date.36  PKA phosphorylation sites are highly conserved among species, and the R region 
has been shown to contain the majority of those sites. 36, 37 This region may be likened to a 
net or web structure that is highly plastic with sub-regions of disorder and coil where 
transitions occur between these states when targeted by PKA and other protein kinases.  
One idea is that a randomly fluctuating R region becomes locally ordered with coil structures 
after regulation to permit the binding of other proteins to assemble a hub (or hubs).  Thus, 
the R region acts as a molecular fly trap for passing cellular protein prey after protein 
phosphorylation imparts order through multiple negative charges.  Thus CFTR does not act 
alone and a recent review of the data suggests that calmodulin is attracted to CFTR by this 
R region.12 This R region may lie to the side of the structure based on atomic maps.38 
Interestingly, recent evidence from three-dimensional (3D) structures of both zebrafish 
(Danio rerio) and human CFTR from cryo-electron microscopy at a medium resolution of 3.7 
Å in the absence of ATP reveals a) a funnel-shaped anion conduction pathway lined by 
positive charged residues, b) a single gate at the extracellular surface, and with c) the 
dephosphorylated regulatory domain located between (and not to the side of) the two NBDs 
preventing dimerization and channel opening.39, 40 The authors suggest that spontaneous 
disengagement of the R domain from its docking site in the intracellular vestibule likely leads 
to phosphorylation by PKA, correlating the channel gating with ATP hydrolysis rates.  
Comparative analysis of above conformations with zebrafish CFTR in its phosphorylated and 
ATP-bound form, shows large conformational changes after phosphorylation and ATP 
binding that promote channel function including NBD dimerization, disengagement of the R-
domain from its inhibitory position and opening of the pore to the cytosol but not the 
extracellular space.41  Although these recent advances have provided such important and 
invaluable insights into CFTR function, further work remains to be done since CFTR function 
is also impacted by a complex of CFTR-associated proteins.  
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A key step in CFTR¶V UHJXODWRU\ functions is a consequence of targeting of PKA to CFTR. 
This approximates PKA, certain Na+/H+ exchanger regulatory factor isoforms (NHERF1 or 
NHERF2) and the cytoskeleton through the A kinase anchoring protein AKAP78 (ezrin, a 
members of the ERM protein family).  The last two moieties play regulatory and structural 
roles in the stabilisation and relocation of many plasma membrane bound proteins.  For 
example, ERM proteins act as a bridges-cum-molecular switches which when activated by 
PKC, PIP2, and Rho-GTPases promoting interactions with NHEFR1 so as to bind more 
tightly with CFTR. This may cause dimerization of CFTR and formation of a micro-domain 
where PKA can more efficiently activate CFTR.42  ERM proteins are also implicated (along 
with phosphorylation by kinase CK2) in optimally targeting sodium channels to their correct 
locations in the cytoskeleton of neurons. This is consistent with local substrate channelling of 
the constitutive activity of kinases such as NDPK and CK2 inside a new hub structure 
located near CFTR that may be shielded from the cytoplasm.  Importantly, CK2 is also 
essential for sodium channel function by phosphorylating two different sites and others 
suggest that NDPK and CK2 may interact in vitro, but this remains to be confirmed. 
Mechanism of action of the CFTR anion channel 
It has been proposed, that pre-dehydrated, negatively charged chloride ions accumulate 
around the positively charged sections of the transmembrane domains that form the CFTR 
channel¶VSRUH. Ions such as chloride can then flow freely through the pore upon opening of 
WKH FKDQQHO¶V JDWH.43-45  The course of events is initiated by the phosphorylation of the R 
domain of CFTR at multiple sites by an anchored PKA enzyme 46, 47, accompanied by the 
binding of ATP molecules to the two different ATP-binding sites on the inner faces of the 
cytoplasmic nucleotide-binding domains of the CFTR. ATP has been shown to be required 
for the opening of the phosphorylated CFTR channels. Channels do not open in the absence 
of ATP and the open channels close within 1 s of removal of ATP.12, 30, 47, 48 The binding of 
ATP to the nucleotide-binding domains of phosphorylated CFTR promotes the initiation of 
the channel gating cycle.49 In most epithelial cells, the normal ATP concentration of ~ 2 mM 
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is thought to be sufficient to ensure channel activation. Additionally, it has been observed 
that the opening and closing of the CFTR channel is a cyclical process, with the activated 
channels showing typical opening durations of only hundreds of milliseconds.49, 50  According 
to a currently accepted model, this results in conformational changes, which in turn leads to 
the opening of the channel.51  This channel-gating cycle is terminated by the subsequent 
hydrolysis of the ATP promoted by the enzymatic activity of one NBD, upon which the ADP 
is released. Interestingly, ADP release is not reversible (ADP is not turned into ATP in the 
gating cycle under experimental patch clamp conditions in vitro).  Moreover, the energy 
released during the ATP hydrolysis reaction is not used for the chloride µSXPSLQJ¶ RU
transport49, 52, 53. It is instead proposed that the channel gating of CFTR can be promoted by 
non-hydrolysable ATP analogues, for example the AMP-PNP.54, 55 Confusingly, it has been 
demonstrated, that apart from having an ATPase activity (ATP + H(2)O --> ADP + Pi), the 
CFTR enzyme may also manifest adenylate kinase activity (ATP + AMP ֐ 2 ADP), which 
has been proposed to be essential to the normal CFTR activity in the epithelial cells of the 
lungs.46, 56, 57  These workers propose that both ATP and AMP interact with CFTR, albeit at 
separate binding sites, and that those nucleotides could mutually influence their interaction 
such that CFTR acts like an adenylate kinase.58  This remains a controversial idea but is 
consistent with data linking the AMP activated kinase (AMPK) to the inhibitory control of 
CFTR channel regulation.  Additionally, the cell essential protein kinase CK2, formerly 
casein kinase 2, is dominantly permissive over PKA in CFTR channel opening.  For 
example, using two independent approaches with different in vivo preparations, coupled to 
data when human CFTR is expressed in different model systems, inhibition of CK2 prevents 
activated PKA from maintaining an open channel.  Indeed, prompt closure occurs after about 
ninety seconds of CK2 inhibition in patch clamp experiments and despite adequate 
concentrations of ATP.  Importantly, when a mutated and inhibitor-insensitive version of CK2 
is present alongside CFTR, pharmacological CK2 inhibition can no longer overcome PKA 
activation of CFTR. These new recent data point to an inability to maintain an open CFTR 
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when CK2 (with active PKA) is inhibited suggesting that yet another control point may be 
operant during anion transport.59 
The thermodynamic basis of the CFTR channel gating cycle is still not understood, with 
contradictory opinions.  Although the available data supports the assertion that dimerization 
and trapping of ATP between opposed and inverted NBD1 and NBD2 domains drives the 
process of channel opening, and that the ATP hydrolysis leading to the disruption of the 
NBD1-NBD2 interaction, results in channel closing, it is not clear how conformational 
changes in NBDs are translated into channel gating.  Some studies have suggested that the 
process of the CFTR channel opening is temperature-dependent, while the closing of the 
channel was suggested to be only weakly dependent on ambient temperature.54, 60  Thus the 
event of the ATP binding, rather than ATP hydrolysis, has been suggested to be responsible 
for the opening of the CFTR channel.60  However, the measurements of the contribution of 
the enthalpy and entropy to the energetic states of the open and closed state of the channel, 
which were obtained by the different groups (albeit using different subcellular cell purification 
methods and electrophysiological methods) are inconsistent and will require further 
elucidation.  The channel gating of CFTR is not a thermodynamic µQHDU WR¶ equilibrium 
reversible process, and thus, the non-equilibrium thermodynamic analysis may provide more 
consistent data and allow better understanding of the energy profile of the gating mechanism 
of CFTR.49, 61  It has been suggested, that the large activation entropy and activation 
enthalpy for channel opening may mean that the conformational transition at the gate may 
spread across domains while the channel is still closed and after dimerization of NBD 
domains is in place49, 61.  On the other hand, the small activation entropy for closing the 
channel could be more in line with the dissolution of a single phosphate bond in a trapped 
ATP molecule.61  This would suggest, that the channel closing is a process that does not 
involve the substantial conformational changes of the protein, and that indeed, this 
transitional step precedes the disruption of the NBD1-NBD2 dimer52, 61, 62.  Such a controller 
domain might include the C-terminal tail that is also implicated in the gating of the pore 
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because deletion of an acidic stretch in the tail close to the binding site for AMPK (see 
below) alters channel gating.63  Interestingly, there is a site immediately adjacent to this 
acidic tail that is stoichiometrically phosphorylated by kinase CK2 at T1471 when peptides 
corresponding to this tail are used as CK2 substrates.  Mutation of this T1471 site in full 
length CFTR is also implicated in the fragmentation of the protein such that phosphomimics 
such as T1471D p attenuate CFTR fracture into N and C terminal halves.28, 64  Thus at the 
time of writing, the molecular mechanisms by which the conformational changes due to the 
1%'V GLPHUL]DWLRQ OHDG WR WKH &)75¶V FKDQQHO RSHQLQJ remain clouded and in particular, 
how a supposedly remote tail domain of CFTR PLJKW µWDON¶ WR WKHSRUH LVDSX]]OH WKDWZLOO
need a better picture of the full length of the CFTR structure that is currently lacking at 
atomic resolution.  The combined data predict that the negatively charged region of the tail 
when augmented further by the addition of (CK2-transferred) negative phosphate charge will 
manifest an interaction with the pore.  In this context, an earlier proposal that CK2 and 
NDPK can interact with each in vitro other remains an intriguing challenge for future work. 
This is especially interesting given that the transition between the monomeric and multimeric 
states of CK2 is itself dependent on ionic strength. It is tempting to speculate that just as the 
R region of CFTR has been proposed to be a trap for proteins such as calmodulin,12 perhaps 
multiple C-terminal interacting proteins whose expression might differ in different cell types65 
might also increase the functional tethering of CFTR in different cell contexts. Perhaps 
consideration should be given to the hierarchy of potential steric restrictions when multiple 
protein partners try to bind to the tail of CFTR. 
In a recent study with other ABC proteins, it has been demonstrated that the ATPase and 
the adenylate kinase activities are coupled such as in the ABC lipid A flippase MsbA, and in 
the LmrA and TmrAB family members. It may be that this feature could represent a general 
characteristic of the ABC transporters that might have been retained by CFTR.66  Recent 
authors have shown, that the MsbA, a typical ABC pump, is able to catalyse both the ATP 
hydrolysis and the adenylate kinase reactions, and that the coupling could have a cyclic 
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character. Cycling may depend on concurrent physiological conditions, in which the ATPase 
activity would be most prominent under the normal physiological conditions, and the 
adenylate kinase activity would be most prominent under low ATP/high ADP cellular level.  
Coupling of the two activities (perhaps with AMP-kinase) would thus provide a mechanism 
that would allow flexibility for the ABC transporter to function under variety of physiological 
conditions, with adenylate kinase playing a role during physiological stress (such as the ATP 
depletion).  In this context, it is important to remember that the cell metabolic VHQVRUµ$03-
NLQDVH¶ LVDPLVQRPHUEHFDXVH WKLVFRPSOH[SURWHLQ LVERWKDQ$03-stimulated and ADP-
sustained kinase that binds to the C terminus of CFTR and phosphorylates the R region to 
keep CFTR shut at baseline.  NDPK-A is central to this effect and PKA overcomes this 
blockade. Thus, it is possible that the coupled ATPase-adenylate kinase mechanism could 
be a general feature of ABC transporters, including the CFTR, and could represent a 
physiologically relevant feature of those proteins and protein complexes, representing their 
mode of functioning under the conditions of energy depletion.56, 58, 62  A key unexplained 
aspect of CFTR function is the discrepancy between the slow rates of ATP hydrolysis 
observed with purified CFTR and the fast gating kinetics of channel opening.67-69 We 
speculate that, as for many aspects of NDPK function (G proteins, ion channel and dynamin 
regulation, cell migration, Ras scaffold assembly, the fast turnover of NDPK (1000 per sec) 
could supply the missing link between the biochemistry and the electrophysiology. 
5HJXODWLRQRI&)75DFWLYLW\E\WKHƍ-AMP-activated protein kinase (AMPK) 
It has been established that phosphorylation of the R domain of CFTR is essential for the 
opening of the ion channel.56  However, CFTR function is basally inhibited by the ƍ-AMP-
activated protein kinase (AMPK).  It has been shown by yeast two hybrid and functional 
studies with interfering peptides, that the COOH-terminal regulatory domain of the catalytic 
Į VXEXQLW RI WKH $03. LQWHUDFWs with residues 1420±1457 of CFTR70, and that AMPK 
predominantly phosphorylates CFTR at Ser-768 in the R domain of the CFTR protein.71  The 
ƍ-AMP-activated protein kinase is a principal metabolic sensor that responds to conditions 
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of nutritional demand and to the corresponding changes in the AMP/ATP ratio. AMPK exerts 
this function by inhibiting the ATP-consuming pathways in the cells 72, and by regulating 
other energy demanding metabolic processes, such as glucose-dependent gene expression 
and cellular glucose uptake.73  AMPK is a ubiquitously distributed (albeit with variable 
subunit composition) as a highly conserved heterotrimeric multi-substrate Serine/Threonine 
(Ser/Thr) kinase.  ,W LVFRPSULVHGRIDFDWDO\WLFVXEXQLWĮRUĮDQGDUHJXODWRU\VXEXQLW
ȕRUȕDQGDVLQJOH$03$73ELQGLQJVXEXQLWȖȖRUȖ7KHPXOtiple isoforms show 
differing tissue distributions.  /RZ$73WR$03UDWLRFDXVHV$03WRGLVSODFH$73IURPWKHȖ
subunit of AMPK, initiating a conformational change in the protein. That change allows the 
phosphorylation at Thr172 residue of AMPK by one of the upstream kinases followed by the 
DFWLYDWLRQRIDFDWDO\WLFĮVXEXQLW. 74  (DFKRIWKHȖVXEXnits of AMPK has three AMP-binding 
sites, two of which are capable of reversibly binding either AMP or Mg2+-ATP and thus 
regulating the kinase activity of the AMPK protein, whereas the third AMP-binding site of 
AMPK binds AMP molecule irreversibly.75  Under physiological conditions, whereby the 
concentration of the Mg2+-ATP is higher than that of the ADP, and much higher than that of 
the AMP, regulation of AMPK activity is also facilitated by a significantly higher affinity of 
AMPK for binding ADP than Mg2+-ATP.  Although a rise in the local concentration of ADP 
and the corresponding decreasing ATP levels do not lead to the allosteric activation of 
AMPK, such conditions further enhance AMPK activity by preventing dephosphorylation of 
AMPK by phosphatases.75  Working with the Hallows group, we reported that just one 
isoform of AMPK (alpha one and not two) and one isoform of NDPK (A not B) interacted with 
each other in the context of CFTR function.  The data are supportive of a complex link 
between the activities of AMPK and NDPK-A which co-localise23 (see below).  This is 
compatible with our early data on chloride as a signal to phosphohistidine generation and 
perhaps there exists a latent functional inter-regulation between NDPK, that is part of an 
epithelial, chloride-sensitive, membrane-delimited phosphorylation system working with 
membrane-bound AMPK76 in association with CFTR. 
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It is now HYLGHQW WKDW&)75LQWHUDFWLQJSURWHLQV&,3¶VSOD\DQLPSRUWDQWUROH LQUHJXODWLQJ
CFTR function.13 However, most CIPs have been identified under baseline conditions and as 
such are inhibitory to CFTR function.77-79  One such protein belongs to a family of t-SNARE 
proteins that are often found on endosomes.  A model was proposed invoking the idea that 
at baseline, cell surface CFTR is held inactive (in complex with proteins inhibitory to CFTR 
function ± e.g. syntaxin 1A, syntaxin 8; AMPKD 77-79) but after PKA is activated, additional 
component plasticity is induced which is permissive for channel opening.22  In this regard it 
was demonstrated that the calcium binding protein annexin A2 (anx 2) and S100A10 can 
form a functionally important complex with CFTR in airway and gut epithelial cells in a cAMP, 
PKA and protein phosphatase (calcineurin A) dependent manner.18  Interestingly, disruption 
of this complex significantly attenuates CFTR function in wild type cells.  In CF cells bearing 
the common mutant form of CFTR, this PKA/CnA-driven anx 2-S100A10 complex with 
mutant CFTR fails to form.80 The recent links between cell calcium and PKA and CFTR 
function have been reviewed elsewhere by Hanrahan, Kunzelmann and Mehta 20, 81 (and 
cited by Forman-Kay12) and will not be discussed further here, but we note that calcineurin 
coupled to the calcium binding properties of the annexin family and calmodulin itself now 
firmly place this regulatory cation with the CFTR family of hub proteins. 
Regulation of CTFR function by various isoforms of Nucleoside Diphosphate Kinase 
(NDPK) 
NDPK-A (NME1, nm23-H1) and NDPK-B (NME2, nm23-H2) lie within group I of this histidine 
kinase family as two closely family members that share 88% sequence similarity.  They are 
thought to exist in heterohexameric forms but our data suggest that they do not always 
create mixed moieties.  Despite their close homology, the intracellular functions of NDPK-A 
and NDPK-B are markedly different and they do not co-localise to the same macromolecular 
complexes.  For example, others have shown that NDPK-B, but not the NDPK-A, can bind 
and trans-SKRVSKRU\ODWH WKH ȕ-subunit of G-protein, thus increasing the activiW\ RI WKH Į-
subunit of G-protein.82, 83  This ligand-independent pathway promotes baseline cAMP 
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synthesis. NDPK-B has been implicated in the regulation of the G protein-coupled receptor 
73ȕ DQG LQ WKH UHJXODWLRQ RI WKH DFWLYLW\ RI WKH FDOFLXP-dependent potassium channel 
KCa3.1.84, 85  The latter is also proposed to bind to CFTR.12  The combined observations 
point to the distinct role of the NDPK-B isoform (which binds to NBD1 at residues 351-727), 
and histidine phosphorylation, in membrane-local signalling events that differ from the above 
interactions between NDPK-A, CFTR and AMPK. The role of CK2 remains unclear other 
than its proposed links to NDPK-A. 
As with NDPK-B, the catalytic activity of NDPK-$ DOVR UHTXLUHV WKH µVHOI¶ RU
autophosphorylation event of the catalytic His-118 residue that lies in a water-excluding cleft 
common to both protein kinases.  It has been suggested, that the residue Ser-120 of NDPK-
A, could also be involved in the control of this self-phosphorylation process, perhaps via 
local electrostatic charge repulsion, as the negatively charged residue substitutions at Ser-
120 inhibit autophosphorylation in NDPK-A and disrupt the AMPK-dependent inhibition of 
CFTR 86.  That AMPK and NDPK might combine to retard the function of CFTR has an 
indirect link to faulty fatty acid metabolism found in CF disease. NDPK-A phosphohistidine 
generation regulates the key fatty acid regulator, the cytosolic enzyme ATP-citrate lyase 87, 
which then cleaves acetyl CoA from citrate exported from the mitochondria as a key step 
during cytosolic lipid synthesis. In parallel, AMPK regulates acetyl CoA carboxylase 87, a key 
enzyme generating the malonyl CoA that balances fatty acid biosynthesis versus fatty acid 
uptake by mitochondria. There are two possible mechanisms that could explain the role of 
the NDPK-A and AMPK in such regulation whether it be towards CFTR or in fatty acid 
metabolism.  ,Q WKH ILUVW ³VXEVWUDWHFKDQQHOOLQJ´PRGHOQXFOHRWLGHVDUHGLUHFWO\VXSSOLHG WR
AMPK-alpha-1 isoform by NDPK-A which controls local interconversion of various 
phosphorylated nucleotides.  This would enable the AMPK to acquire local µIRUFHIHG¶ATP 
and inhibit the CFTR Clí channel even in conditions when global ATP is depleted.  The 
second mechanism stipulates that AMPK reciprocally modulates NDPK-A which acts as an 
intermediary between AMPK and CFTR in addition to regulating other signal mediators that 
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modulate CFTR activity.86  Importantly, this NDPK-A/AMPK/CFTR interaction exists 
independently of the NDPK-B isomer88 implying that CFTR may have different partners in 
different parts of the cell membrane with different functions.  One possibility is that new 
membrane formation during membrane recycling needed for embryogenesis might be 
abnormally controlled after CFTR mutation.  This idea is explored using lessons from fly 
genetics and tracheal lumen formation later in this review. 
We have recently demonstrated that a fraction of NDPK-B, following cell stimulation 
translocates from cytosol to the membrane to form a functional complex with CFTR in the 
apical membrane of epithelial cells. 88  This is cAMP/PKA dependent process.  We provided 
a range of biological and biophysical data consistent with the idea that NDPK-B interacts 
with NBD1 in CFTR via a motif involving amino acid residues 36-56 on the surface of NDPK-
B. Thus NDPK-B, a key basal cAMP generator, is ideally placed to alter the function of NBD 
domains of CFTR, the dimerization of which drives ATP hydrolysis and thus the opening and 
closing of the channel.  Since a concerted action of phosphorylation and ATP binding and 
hydrolysis is necessary to activate CFTR channel, it is proposed by these authors that cAMP 
binding may be another controlling event that takes place during this NDPK-B/CFTR 
interaction because cAMP enhances the binding of NDPK-B to CFTR in far Western 
experiments. The details of such a bridging interaction are still not understood but NDPK-B 
is a crucial element of the in vivo transport across the epithelial membranes via the 
regulation of the activity of both CFTR and related ORCC channels, once again stimulated 
by cAMP/PKA.  Further research is necessary to elucidate the interplay of those activities in 
the CFTR under different physiological conditions.  Since functionally, NDPK maintains pools 
of nucleotides for cellular processes central to energy utilization, association of NDPK-B 
SDUWLFXODUO\ ZLWK &)75¶V first NBD is interesting and suggests NDPK-B could play an 
important role in the provision and regulation of local nucleotide pools and or the energy 
required for NBD function.  This may be relevant to the proposal by Dormer et al that CFTR 
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also has a cAMP binding site in its structure and the work of others suggesting homology 
between domains of CFTR and G protein structure. 
CFTR and Calmodulin signalling. 
The tracheal rings of CF babies are incomplete at birth and this may contribute to airway 
dysfunction. NDPK is an important player during tracheogenesis, along with cell calcium and 
the exocytotic cell machinery linked to endosome cycling. Forman-kay and colleagues have 
shown that cAMP and calcium regulation of CFTR coalesce through the acquisition of 
calmodulin binding to the R domain region and Kunzelmann, Hanrahan and Mehta have 
independently proposed a hidden role of cell calcium in CFTR function 12, 20, 81. 
Tracheogenesis is a complex lumen generating process that has been unravelled using the 
power of developmental genetics in the fly.14  It is not common knowledge that flies have 
tracheas that feed the lumen of a branched tubular set of primitive airways that carry oxygen 
to mitochondria rich terminal tips in the fly body.  The embryonic formation of a tracheal 
lumen first aligns and then hollows out adjacent epithelial cells that initially feel for each 
other using filopodial membrane extensions.89, 90  This blind attachment of membrane 
µfingers¶ between cells may be likened to having magnets attached to the tips of each of the 
fingers of your two hands that are free to move in space. If the magnets are such that 
opposite poles are present on each hand, then the fingers will naturally gravitate towards 
each other. Now we have to imagine that the magnets then draw the long sides of the 
fingers together and consequently align each hand in a straight line. It was recently shown 
that adjacent tracheal cells put out finger like extensions from each side that fuse with the 
tips of their neighbouring equivalents during embryogenesis. 90, 91  Next, microtubules attach 
to the fused tips mediating the local arrival of rab 11 and lysosome related organelles (LRO) 
together with Munc13-4/stac calcium binding proteins.  This creates calcium spikes at the 
ER associated with fusion events that make a lumen by cellular hollowing. It is clear from 
parallel experiments in worms that tip migration and movement in other parts of development 
is dependent on NDPK function and Ras signalling through a scaffold protein called KSR.  
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Given that NDPK is dysfunctional in CF cells in that it is overexpressed, mislocalised and 
unable to generate phosphohistidine, a parsimonious explanation for tracheal ring 
malformation in CF babies might relate to an abnormal NDPK, CFTR interaction after CFTR 
mutation.  These ideas, coupled to a link between the two calcium binding domains on Munc 
13-4/stac and their interaction with the t-SNARE role of syntaxin during late endosome 
fusion at the time of early fly tracheogenesis might be related to known interactions of the N-
terminus of CFTR with syntaxins. Interestingly, a novel Munc13-4/S100A10/Annexin A2 
complex has been shown to support acute Weibel-Palade body (WPBs) exocytosis by 
tethering WPBs to the plasma membrane via Annexin A2-S100A10 in endothelial cells 92. 
Thus a wealth of disparate data from embryogenesis where cell tip migration, cell corpse 
disposal, autophagy and endosome fusion events have been recently linked to new 
membrane synthesis through fat metabolism are beginning to point to aspects of CF disease 
that are otherwise difficult to explain.  A key hurdle is that those who research CFTR as a 
cause of CF do not share a research agenda with developmental biologists interested in 
tracheal formation, and in particular it is becoming clear that the embryo can reuse 
exocytotic events needed for mucus release during fetal lumen formation.  For example, 
about 10% of CF babies have interrupted gut lumens at birth of such severity that they die 
without surgery and intensive care.  We need to speak in a common language if those 
working on CFTR, membrane blocks in autophagy, endosome recycling and apical 
membrane function are ever to meet in a common research arena with those interested in 
phosphohistidine generation.  For example, we suggest that new research might aim to link 
up the following ideas: (a) CK2 is log-orders overactive in CF cells bearing the common 
CFTR mutation;93 (b) CK2 phosphorylates key residues on calmodulin located between two 
of its EF hands;94 (c) NDPK controls dynamin as the terminal step in endocytosis and is 
important in cell homing during embryogenesis;95, 96 (d) AMPK and NDPK control adjacent 
supply points for the cytosolic availability of acetyl units needed for new membrane 
synthesis;97 (e) CK2 phosphorylation controls both the localisation and function of sodium 
channels that become dysfunctional after CFTR mutation.98-100  These are some of the 
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known unknowns in CFTR and NDPK research that our model seeks to clarify. But how 
good is our model? In other papers in this series, using the worm NDPK model for example 
developed in Budapest, we observe a variable birth phenotype when just one NDPK gene is 
deleted in early embryonic life. In a related manner, not all patients will exhibit tracheal 
defects in childhood and only ten percent will develop defective gut lumens at birth needing 
surgery to avoid lethality. An important test of validity for any model of any disease is 
whether it can predict the existence of obscure complications. In our work, partly confirmed 
by others on other family members, we find that the first two members of the annexin protein 
family of calcium binding proteins are dysfunctional in CF 21, 22, 101 alongside our reported 
NDPK defects. Combining our data with the known functions of annexin A2 in membrane 
hub assembly and signalling of exocytosis as proposed by the Gerke group 92 for example, 
our model predicts platelet dysfunction in CF. The authors were unaware of this obscure CF 
OLWHUDWXUHDW WKHWLPHRIXVLQJWKHPRGHORI µDQQH[LQ-NDPK-RSDWK\¶DVDSUHGLFWLRQWRRO:H
were gratified to note that others have reported platelet pathologies and one paper 102 has 
even proposed mean platelet volume as a biomarker for CF disease exacerbation. Thus we 
believe our approach linking poor CF phosphohistidine generation to an excess non-
functional NDPK protein levels has predictive power for currently unexplained aspects of the 
disease phenotype.  
In the title, we posed a question about the presence of NDPK A and B in the vicinity of 
CFTR.  If NDPK-B is judged by its established roles in local energy boosting towards other 
proteins, then the next step must be to determine what is being boosted in the vicinity of 
CFTR. Whether that is CFTR itself or some other member of the multi-protein complex 
remains to be determined. For NDPK-A, our own data and that of independent scientists 
such as K Hallows86 concur on a bi-directional regulator of NDPK in the context of AMPK's 
inhibitory role towards CFTR channel function. The other roles of NDPK-A and B in CF 
pathogenesis need to be determined but we note that NDPK-A has been proposed as a 
regulator of RAC in relation to the function of epithelial NADPH oxidases103-105 and that 
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NDPK-B is a core regulator of both ligand-independent G protein function and calcium 
activated potassium channel activity.  
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Figure Legends 
 
Figure 1. Reducing knowledge gaps between NDPK, Annexins and CFTR. 
Since this model was first proposed in 1998 for the F508 site, our new data shows that 
deletion of F508 residue from CFTR knocks in a new binding site for CK2 and mis-controls 
CK2 allosterically along with ATP concentration by log orders. It has recently been 
proposed106 that many members of the Annexin gene family produce proteins that are 
virulence factors in pathogen host interactions. These include the commonest pathogen in 
cystic fibrosis (Pseudomonas aeruginosa) and notable viruses such as HPV type 16, CMV, 
+HSDWLWLV&DQGPDQ\RWKHUV,QDGGLWLRQLWLVEHFRPLQJFOHDUWKDWSDWKRJHQVFDQµVXPPRQ¶
cytosolic annexins to the plasma membrane by subverting cell signals and can even 
promote the extracellular expulsion of such proteins by unknown means. In this context, 
there seems to be an interaction between extracellular receptors for annexins related to the 
Formyl Receptor family and the recruitment of host neutrophils. It is well established that 
such neutrophils accumulate to excess in CF lungs and our work has reported that annexins 
such as annexin A2 and CFTR are found in the same complex.18  Since we have also 
reported that annexins can receive phosphohistidine in their core structure17 and that NDPK 
promotes p-His generation, then it seems a reasonable hypothesis that annexins, NDPK and 
CFTR are to be expected to co-locate.  Our view is that this is a fertile area for future 
discovery given that annexins bring cell calcium sensing, membrane fusion events and 
modification of the host cytoskeleton during pathogen invasion into the picture. Since we 
have found that both annexin function and NDPK function are defective in CF cells, perhaps 
one idea for future work is that host defence might be enhanced when annexin and NDPK 
dysfunction is induced in a carrier of CF which in turn might explain why so many Europeans 
carry the common CF mutation.  For example, we recently have related kinase CK2 directly 
to CFTR stability and CFTR function59 through the C terminus of CFTR at a site proposed by 
Ostedgaard et al to be important in CFTR functioning.63 That site near T1471 in the CFTR 
tail lies very close to the binding site for AMPK. Indeed we have also found that NDPK and 
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AMPK function towards CFTR are related to one another.86 Recently, albeit in another 
tissue, annexin 1 and CK2 have been proposed to be related to one another107 which 
provides independent confirmation that processes linked to cell injury, CK2 and annexin 
function are part of a common signalling pathway.  
The star (  ) refers to factors to consider in the interaction such as the role of fragments 
derived from this part of CFTR after its breakup in the membrane to generate a new 
deletion-induced F508del-based allosteric binding site for kinase CK2 that mis-controls both 
CK2 and substrate level phosphorylation towards proteins such as calmodulin and regulators 
of dephosphorylation including protein phosphatase 1 (PP1) and controllers of protein 
synthesis such as factors controlling chain initiation on the ribosome..  
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